A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. (Q50964092)
Jump to navigation
Jump to search
scientific article published on 16 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. |
scientific article published on 16 February 2012 |
Statements
A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. (English)
1 reference
Tracey E Schefter
1 reference
Kathryn Winter
1 reference
Janice S Kwon
1 reference
Kelly Stuhr
1 reference
Khalid Balaraj
1 reference
Brian P Yaremko
1 reference
William Small
1 reference
David K Gaffney
1 reference
16 February 2012
1 reference
83
1 reference
4
1 reference
1179-1184
1 reference